A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys - Wikidata - wikimedia - TriplyDB

A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys

A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys

http://www.wikidata.org/entity/Q34231426

about

An antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosis Combinatorial peptide libraries: mining for cell-binding peptides.A peptide probe for targeted brown adipose tissue imaging.Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys Ligand-directed profiling of organelles with internalizing phage libraries.Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study Ligand-targeted theranostic nanomedicines against cancer Effective Design of Multifunctional Peptides by Combining Compatible Functions Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic The oncolytic peptide LTX-315 triggers necrotic cell death.Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles.Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue What we talk about when we talk about fat.Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A.Drug design strategies for the treatment of prostate cancer.Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics.Therapeutic assessment of cytochrome C for the prevention of obesity through endothelial cell-targeted nanoparticulate system.The platform for adipose tissue expansion during positive energy balance.Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development.Targeting mammalian organelles with internalizing phage (iPhage) libraries.Comment on "a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys".Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.Peptide-functionalized nanoparticles for the selective induction of apoptosis in target cells.Transcytosis-Targeting Peptide: A Conductor of Liposomal Nanoparticles through the Endothelial Cell Barrier.Addressing apoptosis to tumor zip codes.Peptide-functionalized quantum dots for potential applications in the imaging and treatment of obesity.Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications.

P2860

Q28534020-74784161-442E-4DA9-8130-E61B26A2F931 Q31144876-2E720B6A-8ED2-48A7-8795-1C5A919F8BDB Q34991537-088322A7-3540-4874-A4FA-87EC3D8BEFAD Q35090829-7043E85A-3F82-4BBE-967A-021131B2B041 Q35138545-6047E335-44B9-4A51-BF58-ED924C43205F Q35553061-3076B4EE-ED47-4BD4-BE80-63E869D0F382 Q35592471-35FCF551-864E-41D5-8299-6CE040C57CE5 Q35895637-86B759DC-44C4-4FB0-B1BF-217AF2283FA1 Q35994698-6FDB2A1A-5940-4770-A2F6-939B100637C4 Q36504504-3E7403D1-BA2C-47E3-8621-D2761F59A50D Q36653632-7284B46A-C912-4026-847F-E0735FA9A5F5 Q36780793-1945D394-A7CE-48CD-89F4-A4020F2336C9 Q36931143-CD8269EA-AE5E-432A-9A3D-05D11C2BDF0D Q37123620-EDDAFD84-14CC-4B13-9360-CB5A802F56C7 Q37601812-2B093C2F-B76F-46E8-99A8-48A5E23D0EF6 Q38031743-E972D230-8B6F-465B-9D0B-D01D5515A13E Q38164843-BDA1B28E-955B-4A92-8566-9AF039E97263 Q38264673-5FE5835F-150E-4636-9477-CF81AB18EC88 Q38564219-D3E2E443-7398-473A-9AD8-ECE021BA59BF Q38802167-8CB9A869-19D4-4EF2-B224-57C26F079D79 Q41574157-2FD5E497-94AF-43E6-832A-981594D09905 Q42698659-20E15073-4A2E-43BB-9525-AAFA8CB1F5DB Q43102496-AD565809-200F-46B6-A1B1-4464CBB28AD4 Q43122068-3F30C8CB-1015-4D4B-8FE1-8A4C414E6B06 Q47313263-33412D06-77A7-4775-B4CF-3A27E04A817F Q47330613-57B76E3D-3750-4A39-BB59-523B9AB64003 Q50932492-A48E2D2C-800D-4E8D-9598-E497959C1D41 Q51700936-C6C977DB-7925-40A1-9B47-3C43F5557837 Q53561315-88227F0A-B08F-4AFC-A35E-E8C6E6905E47 Q55304417-019D64D3-66F7-4A98-8B00-323E97F2EF11 Q55355902-A91E1029-6E1C-4168-A657-458C4FFD4349

P2860

A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys

http://www.wikidata.org/entity/Q34231426

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@ast

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@en

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@nl

type

label

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@ast

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@en

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@nl

prefLabel

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@ast

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@en

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@nl

P1433

Q34231426-542D9B39-01BA-4935-902A-82951B374119

P1476

Q34231426-30D2854E-1F00-4821-9DAB-3B1D4224085D

P2093

Q34231426-0A55E867-1C08-4BDC-9FAC-D6CF8461C1A6

Q34231426-3CAA27C6-4A0E-4E29-B0C8-261ECC30943C

Q34231426-477CF74D-2D55-45CC-8C0E-716C58582AC2

Q34231426-4B897CD5-FE47-4829-9C75-EFADC740B8D4

Q34231426-6AFC7F9B-9694-4E92-BF69-1B70D80219B3

Q34231426-7FCCD87B-B428-469E-AB61-1F5FFC6A569C

Q34231426-8738DACE-E540-42E4-8892-92AF017259F6

Q34231426-990508AF-ECDB-43A1-ABAA-9F26D0A474A1

Q34231426-A7417F89-7F8F-452A-954B-D273C31A239E

Q34231426-B937BF4A-709C-4AB7-8A47-F648219E30C6

P2860

Q34231426-0ADD68BA-803B-48F1-BBB3-3BEDE0EB7872

Q34231426-0F44CEB2-DFA2-49E7-A270-8F0EDBADA9ED

Q34231426-100E3096-6CAA-4209-92C5-AA001A364A1A

Q34231426-103DC988-FB6F-4F4B-8989-A0A90F16731D

Q34231426-25EEE7D4-E1F7-4677-A8E2-60C009AE50B9

Q34231426-2AB0B3B2-2151-4304-A71B-D3FCAACB5B64

Q34231426-2B588868-B2DE-4C2B-9EF1-2C7F39FB8FF3

Q34231426-30125E2A-F76B-4D77-ACF9-B2000D3CF63F

Q34231426-3B41D407-94C8-4FDA-9AF1-5888D7FB16B7

Q34231426-4BEB2BB5-8C00-42D1-87BB-A9D7A1A85840

P304

Q34231426-97955BAA-7513-4EE8-B8A0-E7E383D2815A

P31

Q34231426-5AB931F4-FD95-4ADA-A2BC-F226EA46626D

P356

Q34231426-9D24BA0D-8BD0-4B48-BB6E-66E5B68E066E

P407

Q34231426-BAA50410-437F-4539-8145-2AB97FB3B49A

P433

Q34231426-5AC55309-A225-41EA-B5D7-4240F9F672F7

P478

Q34231426-8EF84136-CE20-4873-A62B-60F15A85DE4B

P50

Q34231426-7F96D7F0-F3ED-40BB-BC6E-B71BAF01A510

Q34231426-B41BD1D6-D1D3-4886-A596-6C58E898DBE7

Q34231426-D483317B-3806-426E-89F9-D229CF77A36A

P577

Q34231426-E607AD0F-6075-475B-936A-EB1FA32AD7E1

P5875

Q34231426-64EC420D-1ACC-4307-8A2A-5A0868747E82

P698

Q34231426-7332D07D-C712-4AF0-B5F4-7AEBFECF8CF9

P921

Q34231426-327DE795-FD2D-4FAE-B2FD-F2F3E2636A40

Q34231426-B350C58B-8DE8-4D12-A434-D0874EE7A3EF

P932

Q34231426-36ABC73B-58D1-480D-93E6-2C07B7126B52

P356

SCITRANSLMED.3002621

P1433

Science Translational Medicine

P1476

A peptidomimetic targeting whi ...... in resistance in obese monkeys

@en

P2093

Bruce J Bernacky

http://www.w3.org/2001/XMLSchema#string

Dawn R Christianson

http://www.w3.org/2001/XMLSchema#string

James F Hulvat

http://www.w3.org/2001/XMLSchema#string

Jingfei Ma

http://www.w3.org/2001/XMLSchema#string

Juri G Gelovani

http://www.w3.org/2001/XMLSchema#string

Kim-Anh Do

http://www.w3.org/2001/XMLSchema#string

Kirstin F Barnhart

http://www.w3.org/2001/XMLSchema#string

Lawrence Chan

http://www.w3.org/2001/XMLSchema#string

Mei Tian

http://www.w3.org/2001/XMLSchema#string

Pradip K Saha

http://www.w3.org/2001/XMLSchema#string

P2860

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer

Free fatty acids and insulin resistance

An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment.

Steps toward mapping the human vasculature by phage display.

Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease.

Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse.

Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue.

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.

Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight

P304

108ra112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3002621

http://www.w3.org/2001/XMLSchema#string

P407

P433

108

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Mikhail G. Kolonin

Patrick W Hanley

Renata Pasqualini

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51786103

http://www.w3.org/2001/XMLSchema#string

P698

22072637

http://www.w3.org/2001/XMLSchema#string

P921

P932

3666164

http://www.w3.org/2001/XMLSchema#string